|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_on1256542838 |
003 |
OCoLC |
005 |
20231120010548.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
210615s2021 mau o 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCO
|d OCLCF
|d N$T
|d OCLCQ
|d UKMGB
|d OCLCO
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBC268444
|2 bnb
|
016 |
7 |
|
|a 020278476
|2 Uk
|
020 |
|
|
|a 9780323853248
|q (electronic bk.)
|
020 |
|
|
|a 0323853242
|q (electronic bk.)
|
020 |
|
|
|z 9780323853231
|
020 |
|
|
|z 0323853234
|
035 |
|
|
|a (OCoLC)1256542838
|
050 |
|
4 |
|a RB155.8
|
072 |
|
7 |
|a SCI
|x 049000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 009000
|2 bisacsh
|
072 |
|
7 |
|a PSD
|2 bicssc
|
082 |
0 |
4 |
|a 615.8/95
|2 23
|
245 |
0 |
0 |
|a Reprogramming the genome :
|b CRISPR-cas-based human disease therapy /
|c edited by Vijai Singh.
|
260 |
|
|
|a Cambridge, MA :
|b Academic Press,
|c 2021.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Progress in Molecular Biology and Translational Science ;
|v v. 181
|
500 |
|
|
|a Includes index.
|
650 |
|
0 |
|a Gene therapy.
|
650 |
|
0 |
|a CRISPR activation.
|
650 |
|
2 |
|a Genetic Therapy
|0 (DNLM)D015316
|
650 |
|
6 |
|a Th�erapie g�enique.
|0 (CaQQLa)201-0193146
|
650 |
|
7 |
|a CRISPR activation
|2 fast
|0 (OCoLC)fst02021912
|
650 |
|
7 |
|a Gene therapy
|2 fast
|0 (OCoLC)fst00939638
|
700 |
1 |
|
|a Singh, Vijai.
|
776 |
0 |
8 |
|i Print version:
|z 0323853234
|z 9780323853231
|w (OCoLC)1237633796
|
830 |
|
0 |
|a Progress in molecular biology and translational science ;
|v v. 181.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18771173/181
|z Texto completo
|